Thulium laser (<scp>RevoLix</scp>) vaporesection versus vapoenucleation with morcellator (<scp>P</scp>iranha) for the treatment of benign prostatic obstruction: A propensity‐matched multicenter analysis

Abstract

Thulium:yttrium-aluminium-garnet laser prostatectomy with a morcellator provides superior reduction of prostate volume and better short-term clinical outcomes than thulium:yttrium-aluminium-garnet laser prostatectomy without a morcellator in the treatment of patients with benign prostatic obstruction. Furthermore, thulium:yttrium-aluminium-garnet laser prostatectomy with a morcellator can offer a shorter operative time.